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Abstract
Macropinocytosis defines a series of events initiated by extensive plasma membrane reorganization or ruffling to
form an external macropinocytic structure that is then enclosed and internalized.The process is constitutive in some
organisms and cell types but in others it is only pronounced after growth factor stimulation. Internalized
macropinosomes share many features with phagosomes and both are distinguished from other forms of pinocytic
vesicles by their large size, morphological heterogeneity and lack of coat structures. A paucity of information is avail-
able on other distinguishing features for macropinocytosis such as specific marker proteins and drugs that interfere
with its mechanism over other endocytic processes.This has hampered efforts to characterize the dynamics of this
pathway and to identify regulatory proteins that are expressed in order to allow it to proceed. Upon internalization,
macropinosomes acquire regulatory proteins common to other endocytic pathways, suggesting that their identities
as unique structures are short-lived. There is however less consensus regarding the overall fate of the
macropinosome cargo or its limiting membrane and processes such as fusion, tubulation, recycling and regulated
exocytosis have all been implicated in shaping the macropinosome and directing cargo traffic. Macropinocytosis has
also been implicated in the internalization of cell penetrating peptides that are of significant interest to researchers
aiming to utilize their translocation abilities to deliver therapeutic entities such as genes and proteins into cells. This
review focuses on recent findings on the regulation of macropinocytosis, the intracellular fate of the macropinosome
and discusses evidence for the role of this pathway as a mechanism of entry for cell penetrating peptides.
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Introduction
Most eukaryotic cells have an impressive capacity to
apportion a fragment of their plasma membrane for
invagination into enclosed structures that are then 
pinched off to form intracellular vesicles.The internal-
ized membrane and cargo is then delivered to a 
number of different intracellular destinations such as
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lysosomes and the Golgi or recycled back to the 
plasma membrane. This process is generally termed
endocytosis and is required for processes such as
nutrient uptake and degradation, down-regulation of
activated receptor signalling and antigen processing
in the immune response [1]. Spatial organization of
the endomembrane system and directed transport
on endocytic pathways are both controlled by the cell
cytoskeleton that typically controls centripetal move-
ment to a perinuclear region that also contains lyso-
somes, recycling endosomes, the microtubule organ-
izing centre, centrosome and the Golgi apparatus [2,
3]. It is now known that a number of different internal-
ization mechanisms exist, including uptake via
clathrin coated pits, caveolae and other poorly char-
acterized processes that do not seem to rely on either
clathrin or caveolae [4–8] (Fig. 1).
Phagocytosis is confined to specific cell types
such as macrophages and dendritic cells and the
same is true about macropinocytosis, a process that
shares many features with phagocytosis – see below.
Phagocytosis has been extensively characterized at
morphological and molecular levels [9] but the lack of
recent reviews detailing macropinocytosis is a reflec-
tion of our poor understanding of unique molecular fea-
tures that may govern this event, and in many cell
types, its exact physiological role over other endocyt-
ic processes [10–12]. Given the fact that pathogens
are master highjackers of other endocytic pathways
including phagocytosis, it is not surprising that
macropinocytosis is also utilized by microorganisms
to gain access to the cells. Examples include
Salmonella, Listeria and adenoviruses and
macropinocytosis inducing toxins have also been
described [13–17].
In Dictyostelium, macropinocytosis, demonstrated
by the formation of circular ruffles or crowns,
accounts for most of fluid phase uptake and scanning
electron microscopy (SEM) images of the projecting
circular ruffles demonstrate the extensive reorgani-
zation of the plasma membrane that is required to
form macropinosomes in this organism and in mam-
malian cells [18–20]. The distinct structures of these
circular ruffles compared with other types of regulat-
ed and constitutive ruffling suggest macropinocytosis
represents several distinct processes controlled via
common and specific mediators.
A general feature of macropinocytosis and phago-
cytosis is that the active portion of the plasma mem-
brane is initially not involved in invagination but rather
in an actin-dependent protrusion of the plasma mem-
brane to the external milieu. There is presumably no
regulation regarding the size or morphology of the
enclosed macropinosome but in the case of phago-
cytosis, as previously noted, this is largely pre-deter-
mined by the shape of the enveloped entity [12].
Common to both, however, is that the formed
macropinosome or phagosome may be several
micrometers in diameter; significantly larger than
structures formed from other endocytic invaginations
that rarely exceed 150 nm.
Membrane ruffling and the 
formation of the macropinosome
Macropinocytosis, as a form of pinocytosis, was ini-
tially described by Warren Lewis in 1931 [21]. He ele-
gantly described his 'Motion picture' account of the
appearance of 'waving sheets', macropinosome for-
mation, traffic and subsequent shrinkage in rat
macrophages. Much later, the prominence of
macropinocytosis was shown to be greatly enhanced
by the addition of growth factors and a large portion
of what is now known about this process in
macrophages was gained from experiments per-
formed in cells incubated with macrophage-colony
stimulating factor (M-CSF). More recently,
macropinocytosis has been shown to be prominent
in cell types that do not phagocytose, but this is
mostly a feature of their response to growth factor
stimulation. These include human epidermoid carci-
noma (A431) cells after stimulation with epidermal
growth factor (EGF) [22] and polarized Madin Darby
Canine Kidney epithelial cells following hepatocyte
growth factor/scatter factor (HGF/SF) stimulation
[19]. Constitutive macropinocytosis has been
observed in dendritic cells [23, 24] and NIH3T3
fibroblasts expressing a ruffling kinase [25] but
whether this is a required cellular activity in non-
phagocytic cells is unclear.
The membrane ruffling and macropinocytosis that
immediately follows the addition of growth factors is
accompanied by a rapid increase in uptake of mark-
ers for fluid phase endocytosis [26]. Presumably this
is because of the engulfment of relatively large vol-
umes of extracellular material into these enlarged
macropinosomes. Markers such as fluorescent dex-
trans for fluorescent microscopy and horseradish
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peroxidase for electron microscopy are shown to be
contained in relatively few numbers of large, non-
coated structures whose intracellular fate is dis-
cussed below. Cells infected with Adenovirus type 2
for 10 min show extensive leading-edge ruffling;
prominent also are filopodia in close proximity to
these ruffles and the uptake of fluid phase markers,
as opposed to clathrin coated vesicles is increased
[17]. Similarly, treatment of the same cell line with
EGF results in an extremely rapid (30 s) increase in
fluid phase uptake accompanying extensive mem-
brane ruffling [26, 27]; the resulting increase in fluid
phase uptake is often used as a defining feature of
this process. Within minutes of growth factor activa-
tion, cells boast the appearance of ruffles that cover
the entire surface of the cell including the leading
edge where they manifest as lamellipodia [28, 29].
The appearance and morphology of these is quite
different to the circular ruffles, prominent in
Dictyostelium (phacocytic cups) and HGF-SF stimu-
lated epithelial cells [19, 20, 30, 31].
There is no consensus as to the proportion of
membrane ruffles that end up as macropinosomes [11],
but the formation of an enclosed macropinosome is
more than likely a result of fusion of the protruding
structures or back-fusion of a protrusion with an
unruffled section of the plasma membrane (Fig. 1).
The resulting macropinosomes are, predictably, 
highly heterogeneous in size and morphology. A
requirement for actin and the actin polymerization
machinery on ruffling and phagocytosis including
Rho family members and their upstream effectors
Fig. 1 Endocytic pathways. A, caveolae delivering to caveosomes; B, clathrin independent endocytosis, C, clathrin
coated uptake D, macropinocytosis showing macropinosome formation via fusion of ruffles with each other or the 
plasma membrane, E, phagocytosis. The contribution of a common early endosome in linking these pathways and 
partitioning membranes, proteins and cargo, over delivery to distinct classes of sorting endosomes as depicted by the
dashed lines is unknown.
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such as Ras, PLC and PI 3-kinase, activated them-
selves by receptor tyrosine kinases, suggest that both
processes are similarly organized. Unsurprisingly
both processes are inhibited by actin-disrupting
agents such as cytochalasin A [20].There is also con-
siderable overlap relating to the requirements of pro-
teins regulating these two processes with those
shown to be involved in promoting cell motility [32].
A number of studies have shown, in different cell
types, that activation of the non-receptor kinase v-
Src oncogene promotes macropinocytosis [33–37].
The original demonstration of v-Src effects showed
that its kinase activity led to a constitutive formation
of macropinosomes (in the absence of external
growth factor), a 2-fold increase in fluid phase uptake
and a less significant, 1.3-fold, increase in transferrin
uptake [37]. This small increase in transferrin uptake
compared with much higher stimulation of fluid
phase endocytosis, up to tenfold, is common to many
studies and suggests that transferrin receptors may be
sequestered away from the forming macropinosome.
There is also some recent evidence for this from
experiments in Dictyostelium, showing that this
organism excluded some but not all plasma mem-
brane proteins away from the forming macropinocyt-
ic cup [38]. These studies suggest that the composi-
tion of the macropinocytic cup and nascent
macropinosome is regulated, defining the later as a
unique endocytic organelle rather than just an
enclosed fragment of the original plasma membrane.
As mentioned earlier, once growth of the protru-
sion is finished there will be a requirement for a
membrane fusion event to close leading edges to
fashion the macropinosome (Fig. 1). The identities of
several proteins and lipids that mediate membrane
fusion on the endocytic and secretory pathway are
now known but to date there have been no reports on
the specific requirements for a ruffle–ruffle or
ruffle–plasma membrane fusion protein. The fungal
metabolite wortmannin inhibits lipid kinases that
phosphorylate phosphatidylinositol (PI) at the 3
position; it is a prominent inhibitor of signalling ema-
nating from the canonical PI 3-kinase that generates
PI (3,4,5) P3 from PI(4,5)P2. Nanomolar concentra-
tions of wortmannin inhibit fluid phase uptake and 
the homotypic fusion of early endosomes [39, 40]
and subsequent studies revealed that a number of PI
3-kinase variants were involved in endocytic traffic
with the class III variant hVPS34, that specifically
phosphorylates PI, being prominent on endosomal
membranes and microdomains that are subsequent-
ly enriched in its product PI(3)P [41–43].
In macrophages, wortmannin also affected
macropinocytosis and phagocytosis but the inhibitory
step was in the closure of ruffles or phagocytic cups
rather than the formation of membrane protrusions
that were still clearly observed by SEM [18]. Whether
this was solely due to the known effects of PI 3-kinase
activity on the actin cytoskeleton or whether there is a
separate requirement for a PI 3-kinase in a fusogenic
event to generate an enclosed macropinosome is cur-
rently unknown. A second class III PI 3-kinase
inhibitor, 3-methyladenine, does not impede
macropinosome formation or internalization in EGF-
stimulated A431 cells, but inhibited homotypic
macropinosome–macropinosome fusion [44], sug-
gesting that endosome fusion and macropinosome
fusion share a requirement for PI(3)P.
Rabs and macropinocytosis
Rab proteins are small GTPases that control 
multiple membrane trafficking events in the cell.
Approximately twelve Rab members have now been
located on endocytic structures and several have
been implicated in regulating the dynamics of distinct
endocytic processes [45, 46]. One of these is Rab5
and represents one the most studied Rab variants
that controls several endocytic processes including
invagination at the plasma membrane, endosomal
fusion, motility and signalling. Transfection of cells
with a constitutively active Rab5 leads to the forma-
tion of swollen endosomes not dissimilar in appear-
ance to early macropinosomes [47], and increased
expression of Rab5 together with an active form of
Ras promotes the formation of circular ruffles [48].
In agreement for a Rab5 role in circular ruffling,
transfection of cells with the dominant negative Rab5
mutant (S34N) inhibited circular but not cell edge ruf-
fling [48]. Rab5 involvement in macropinocytosis was
further demonstrated when one of its effectors,
Rabankyrin-5, was found to promote macropinocyto-
sis and partial silencing of Rabankyrin-5 diminished
EGF-stimulated fluid phase uptake [49]. Before
assigning a role for Rab5 in ruffling and
macropinocytosis it is noted that transfection of cells
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with Rab5 S34N has effects on numerous endocytic
pathways thus similar effects may be observed in cells
expressing other early endocytic variants such as
Rab21 and Rab22a that give similar endocytic defects
when their GTP-binding mutants are over-expressed
[45]. Thus these effects on ruffling may point towards
downstream effects of perturbation of the endocytic
pathways in general rather than pointing to Rab5 as
being absolutely required for ruffling. siRNA analysis
and silencing all three Rab5 variants would point fur-
ther to an absolute requirement for this protein in
macropinosome formation and traffic. A second Rab
protein, Rab34, has also been implicated in the forma-
tion of ruffles and macropinocytosis; similarly, the
effects of this protein were shown in over-expressed
systems or cells expressing Rab34 mutants [50].
ADP-ribosylation factors (ARFs) are also small
GTPases that function in membrane traffic [51]. One
variant, ARF6, is localized to the plasma membrane
and in conjunction with the actin cytoskeleton and its
exchange factors and activators, acts as a prominent
ruffling factor regulating macropinocytosis, cell adhe-
sion and migration [52, 53].
The fate of the macropinosome
on the endocytic pathway
The impressive capacity of the cell to internalize its
plasma membrane is somewhat overshadowed by its
ability to later sort components on the endocytic path-
way to a number of cellular destinations. Plasma
membrane derived vesicles rapidly fuse with sorting
endosomes (often termed early endosomes) that rep-
resent a tuboreticular network; indeed the entire
endocytic pathway can be similarly defined [54]. It is
currently unknown how many types of sorting endo-
somes exists within a single cell or the extent of mix-
ing of membrane and cargo that then occurs between
different pathways. There is now evidence to suggest
that molecules entering via clathrin coated vesicles
may be sorted before fusing with early endosomes or
even prior to completion of the budding step to gener-
ate the clathrin coated vesicle [55–57].
The fate of a protein entering these sorting com-
partments is in part determined by both the nature of
its lipid environment and by sorting signals it pos-
sesses on its cytoplasmic and transmembrane
domain(s). It is in the interest of the cell to ensure
that some proteins such as activated receptors are
trafficked to the degradative lysosomes and that oth-
ers such as the transferrin receptor are recycled back
to the plasma membrane for another round of func-
tion. To fulfil this requirement, it organizes on endoso-
mal membranes the formation of retrieval and sorting
multi-protein complexes such as Endosomal Sorting
Complexes Required for Transport (ESCRT) and
retromer, that either interact with the cytoplasmic
portions of endocytosed molecules, with distinct
lipids on the endosomal membrane or with endoso-
mal located regulatory proteins. The reader is
referred to these reviews on specific aspects of the
regulation of sorting and retrieval on the endocytic
pathway [58–62].
Fluorescence and electron microscopy studies
show early macropinosomes as large, uncoated vac-
uole like structures identified most commonly with an
internalized fluid phase tracer such as dextran or
horseradish peroxidase. Numerous groups have
attempted to map the route the macropinosome
and/or its associated cargo traverses downstream of
the plasma membrane and from data review it is
unlikely that they mature, in all cell types, via a com-
mon pathway to a single pre-defined location [12].
The intracellular dynamics of macropinosomes was
first extensively studied in EGF stimulated A431
fibroblasts [22, 63] and macrophages [64–66] and
later reviewed [12]. In macrophages, the
macropinosomes followed a somewhat conventional
centripetal route to tubular lysosomes; as determined
by acquisition and loss of classical marker proteins
such as the transferrin receptor and Rab7, identifying
early and late endosomes, respectively.There were many
similarities to this process when macropinosomes
were studies in Dicyostelium [67] or in mammalian
cells transfected with GFP-c-Src [34].
In contrast to observations in macrophages, there
was little evidence of co-localization of EGF-induced
A341 macropinosomes with other endocytic markers
such as transferrin, neither were macropinocytic
cargo delivered to lysosomes in these cells [22]. In a
separate study, the transferrin receptor was found to
be enriched, via exocytosis, on plasma membrane
ruffles of stimulated cells thus suggesting that mem-
brane for ruffles and possibly macropinosome forma-
tion was provided in part from the endosomal path-
way [29]. Early macropinosomes are however often
noted to be devoid of transferrin and/or the transferrin
J. Cell. Mol. Med. Vol 11, No 4, 2007
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receptor, strengthening the idea that sorting is occur-
ring at the plasma membrane during ruffling and
macropinosome formation, and that distinct lipid
domains contribute to generate ruffles and
macropinosomes.
More recent experiments in A431 cells demon-
strated a higher degree of co-localization of EGF, and
transferrin in macropinosomes but the fraction of
EGF on enlarged structures or ruffles seemed to be
significantly higher than transferrin, that was pre-
dominantly localized to more widely distributed
smaller vesicles [49]. Evidence for macropinosomes
being, at least at some stage, unique organelles
comes from tracer co-localization experiments showing
homotypic, i.e. macropinosome-macropinosome fusion
but there was little evidence of macropinosomes fus-
ing with other endocytic structures [22]. In
Dictyostelium, the situation was somewhat different
as much smaller endosomes appeared to contribute
further to internalized macropinosomes suggestive
of heterotypoic fusion; homotypic fusion was also
prominent [68].
The use of alternative markers of endocytic path-
ways has recently enhanced our knowledge of the
trafficking of macropinosomes though, as expected
there is some discrepancy as to whether they
progress as distinct entities. Antibodies recognizing
the early endosomal autoantigen 1 protein EEA1 are
now commonly used to label early endosomes in
mammalian cells. On these structures, EEA1 binds
to PI(3)P via its FYVE domain, falls off the endoso-
mal membrane in the presence of wortmannin [69],
binds other regulatory proteins such as Rab5 and
regulates early endosome fusion and sorting
[70–72]. Expression of Rabankyrin-5 in A431 cells
resulted in the formation of swollen vesicles that
were later defined as macropinosomes and EGF
stimulated cells also sequestered endogenous
Rabankyrin-5 on these structures [49]. The larger
macropinosomes also harboured Rab5 but did not
contain EEA1, however smaller structures that
appeared to be more mature macropinosomes con-
tained all three proteins. Earlier studies showed that
EEA1 transiently associated with macropinosomes
as 5 min macropinosomes were essentially EEA1
negative and then over a 25 min period EEA1
labelling increased and then decreased as the
macropinosomes evolved; in agreement with previ-
ous studies there was no evidence of the progression
of macropinosomes to typical late endosomes and
lysosomes [73]. In dendritic cells, early
macropinosomes (<4min) were depleted of early
endocytic markers but then acquired EEA1 and the
transferrin receptor, however, the macropinocytic
cargo did not then co-localize with markers of late
endosomes and lysosomes [74]. In a separate study,
also in A431 cells, immature macropinosomes were
labelled with early endocytic markers EEA1 and
Rab5 and also Rab7, a classical marker of late endo-
somes and lysosomes [75]. These studies were how-
ever performed in Rab7 over-expressing cells, that in
the absence of stimulus, often display swollen struc-
tures, reminiscent of macropinosomes [76]. This sug-
gests that macropinosomes rapidly develop classical
early endosome characteristics before developing
into late endocytic structures or diminishing in size
and loosing their identity via membrane retrieval.
A role for nexins in
macropinosome sorting
A member of the sorting nexin (SNX) family of proteins
was recently shown be involved in macropinosome
maturation [75]. SNXs comprise a family of approxi-
mately 30 peripheral membrane proteins that are
characterized by having a SNX phox homology (PX)
domain that bind most notably to PI(3)P [77, 78]; a
number have therefore been located on endosomal
structures. A least seven members also contain a
Bin/Amphiphysin/Rvs (BAR) domain that is thought to
aid in the binding of the PX domain to membrane but
also to sense membrane curvature [79].
SNX5 was shown to co-localize with EEA1 on
microdomains of macropinosomes but was also
apparent in tubular extensions that seemed to
emanate from these structures [75]; tubulation of
macropinosomes was noted earlier in mammalian
and amoeba cells [22, 68]. This suggest that tubula-
tion may be one mechanism that helps retrieve mem-
brane back to the plasma membrane, resulting in the
shrinkage of the macropinosome that was noted in
the first demonstration of macropinocytosis [21].
SNX5 and other sorting proteins may be working in
conjunction with microtubules that ran in parallel to
the tubular membranes and also appeared to organ-
ize themselves as a mesh around the
macropinosome [75]. Similar conclusions come from
research in Dictyostelium showing that microtubules
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were closely associated with macropinocytic vac-
uoles and tubular extensions emanating from them;
macropinosome fusion was also dependent on
microtubules [68]. There may therefore be a require-
ment for alternate protein complexes akin to ESCRT
and retromer to retrieve and sort macropinosome
membrane and cargo.
Whether the formed tubules recycle back to the
plasma membrane to replete lost membrane is
unknown but studies in dendritic cells suggest that
retrieval may rather be a function of the regulated
exocytosis of structures, enlargeosomes, that fuse
with the plasma membrane in a calcium-dependent
fashion [74]. The enlargeosome was initially
described as being a unique vesicular compartment,
showing no co-localization with conventional endo-
lysosomal markers but containing the protein
Desmoyokin-AHNAK, that was recruited, with the
enlargeosome, to the plasma membrane. This exo-
cytic response to macropinocytosis in dendritic cells
is therefore quite different to that described in EGF-
stimulated cells where transferrin positive vesicles
served the function of enlargeosomes [29]. There is
also some evidence for the involvement of the endo-
plasmic reticulum in the traffic of material entering
via macropinocytosis, or in providing membrane for
macropinosome formation [80].
Cell penetrating peptides as 
vectors for drug delivery
Our understanding of disease processes will grow
exponentially now that the human genome is unrav-
elled and that tools are available to more easily study
differences in expression and sequence of genes
and proteins. In the wake of this is an increasing
demand for the design of therapeutic entities to
reverse disease-causing events at the intracellular
level. This calls for targeting organs and cells, and
third-order targeting of intracellular targets in the
cytosol or in membrane bound compartments [81].
In the realm of gene delivery the target is most often
the nucleus but it is becoming apparent that a num-
ber of other organelles are potential drug delivery
targets. Endocytic pathways provide highly efficient
routes that enable drug delivery researchers the
opportunity to introduce a macromolecular entity
across the plasma membrane [82], however the like-
lihood exists that a significant fraction, perhaps all, of
the therapeutic payload will be recycled or will end up
degraded in lysosomes. Holy Grails in drug delivery
research are molecules that somehow promote the
escape of therapeutic entities such as genes and
proteins from early stages of the endocytic pathway.
A wide variety of strategies have been designed
including the use of bioresponsive agents that modi-
fy themselves and the endosome environment in the
decreasing pH that accompanies transit in the endo-
lysosomal system, through to the use of domains of
proteins, often from pathogens, that have been
shown to translocate through biological membranes.
These include the hundereds of amino acid
sequences that are now classified as cell penetrating
peptides (CPP) or protein transduction domains and
the reader is referred here to reviews in an edition of
Advanced Drug Delivery Reviews dedicated to pro-
tein and peptide-mediated translocation [83].
The most intensely studied CPPs include those
derived from the transduction domains of the HIV
transcription factor TAT (HIV-TAT peptide) or the
Drosophila melanogaster homeobox protein
Antennapedia (penetratin), together with synthetic
oligomers of arginine (R4-R16). The sequences of a
few of these are shown in Table 1 and common to
many, but not to all, is the relatively high number of
positive amino acids lysine and arginine over other
amino acids. In view of the heterogeneity of their
sequences and properties they are often further sub-
classified to arginine-rich, amphipathic, non-basic
and more specific criteria [84, 85]. The charge on the
cationic peptides allows them to interact strongly with
negative charges on the plasma membrane and this
interaction is reduced in cell lines with defects in
heparan sulphate and glycosaminoglycan synthesis
[86–88]. Beyond interacting with cells, a number of
CPPs traverse biological membranes, be it alone or
attached to much larger cargo ranging from small
molecule drugs to antisense oligonucleotides, siRNA,
plasmids, peptides and proteins [89–92]. They do not
appear to be cell-type specific and their incorporation
into targeting and intracellular delivery complexes
show they hold great promise as agents for enhanc-
ing translocation across biological barriers. Their
uptake mechanisms have therefore been studied in
great detail with a view to the subsequent design of
more efficient delivery and translocating systems.
Initially there was agreement that a number of
CPPs entered cells in a temperature independent
J. Cell. Mol. Med. Vol 11, No 4, 2007
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manner and once inside they rapidly entered the
nucleus. Later, a large part of their interaction with
cells and nuclear delivery was revealed to be a prod-
uct of fixation, and that a significant fraction of what
was termed cell associated peptide was confined to
the plasma membrane [93, 94]. All microscopy and
cytometry experiments with these entities are now
performed in live cells, and trypsinization and
heparin washing is now commonly used to reduce
plasma membrane binding prior to quantifying intra-
cellular peptide.
Confocal microscopy highlights the fact that the
peptides enter vesicular structures in a number of dif-
ferent cell types including the HeLa and A549 cells
shown in Figure 2. But despite extensive study there
is no consensus regarding the uptake mechanism
and whether there is a preferred entry route. As pre-
viously mentioned, hundereds of CPPs have now
been described and as there is no consensual
sequence, it is unlikely that a common mechanism of
entry exists and this is highlighted in a number of
studies [87, 95–97]. Equally, any cargo that they are
attached to could also influence cellular interaction,
endocytosis and intracellular dynamics [96, 98, 99].
Focus here will be on experiments performed with
fluorescent variants of HIV-TAT, oligoarginines and
penetratin (Table 1).
The case for and against
macropinocytosis
In EGF stimulated A431 cells the increased fluid
phase uptake that accompanies macropinocytosis
was found to be inhibited by the ion-exchange
inhibitor amiloride, however, endocytosis of the trans-
ferrin receptor was unaffected by this drug [63].
Similarly, the enhanced fluid phase uptake, driven by
adenovirus-induced macropinocytosis was inhibited
by 5-(N-ethyl-N-isopropyl) amiloride (EIPA), a more
potent analogue [17]. Consequently, these agents
are regularly used to define uptake via macropinocy-
tosis, but amiloride and EIPA also strongly inhibit
receptor-mediated uptake of albumin in renal proxi-
mal tubule-derived epithelial cells [100–102]. Here, it
is unlikely that uptake is via macropinocytosis and
albumin has been shown to enter cells via clathrin
coated pits and caveolae [103–106]. To various
extents, EIPA also inhibits the uptake of HIV-TAT pep-
tide and oligoarginine peptides raising the possibility
of a link between macropinocytosis and uptake of
CPPs [87, 107, 108], and supporting previous stud-
ies showing amiloride inhibition on the uptake of a
TAT peptide-Cre protein conjugate [109]. The
microscopy studies to date show the peptides, as
single fluorescent conjugates, labelling typical
pinocytic vesicles and tubules (Fig. 2) as opposed to
macropinocytic vacuoles but careful analyses of their
location immediately after addition to cells, when
macropinosomes may be much more pronounced,
has yet to be performed. One reason for this is that
their extensive binding to the plasma membrane
makes interpretation at early time points quite diffi-
cult, especially when the amount of internalized pep-
tide is low and thus the fluorescent signal weak. An
exception to this rule are leukaemic cells such as
K562 and KG1a that intriguingly show minimal plasma
Fig.2 Localization of D-R8 in cells. HeLa (A) and A549 (B)
cells were incubated for 1 hr at 37C with 2 µM of the 
D-enantiomer of R8-Alexa488 peptide (RRRRRRRRGC-
Alexa488) and immediately analysed by scanning con-
focal fluorescence microscopy combined with scanning
Direct Interference Contrast. Shown are superimposed
images from 25 to 30 sections through the Z-axis. The
peptide-labelled vesicles in these cells are concentrated
in a perinuclear region but it remains to be seen whether
any are, or are derived from, macropinosomes. Previous
studies in HeLa cells show a significant fraction of these to
be late endosomes and lysosmes [110]. Scale bar 15µM.
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membrane binding of HIV-TAT or octaarginine 
peptides [110–112].
There is strong evidence that these peptides pro-
mote undefined actin rearrangements and this like
membrane ruffling may be a Rac-dependent activity
as both TAT peptide and octaarginine (R8) rapidly
increased the levels of activated Rac and also
induced the formation of lamellipodia [87]. In other
studies CPPs HIV-TAT and nona-arginine induced the
rapid internalization of the EGF- and tumour necrosis
factor receptor[113] and it will be interesting to deter-
mine whether there is a coincidental increase in fluid
phase endocytosis in these cells. Support for this
comes from observations that the TAT–Cre conjugate
and TAT peptide conjugated to a fusogenic peptide,
enhanced fluid phase uptake of 70 KD dextran [109].
A number of studies have now shown that a fraction
(up to 90%) of HIV-TAT and R8 peptide uptake at 
37C occurs independently of inhibition by ion-exchange
inhibitors EIPA and amiloride [87, 108, 110, 111].
Uptake of R8 and HIV-TAT in leukaemia cells was rel-
atively insentitive to EIPA but at concentrations higher
than 50 µM a much higher fraction of the peptide was
found in the cytosol [111]. In a separate study, the
cytosolic delivery of oligoarginine and uptake of a
CPP-immunogenic antigen chimera was unaffected by
amiloride treatment [114, 115]. Amiloride and
amiloride analogues have additional quite dramatic
effects on the actin cytoskeleton and cell morphology
[116], and their capacity to inhibit macropinocytosis
may be mediated through actin.The sub-cellular distri-
bution of conventional markers for early and late endo-
somes, EEA1 and Lamp1, were also highly sensitive
to amiloride and EIPA treatment [111] and of specific
note for endocytosis studies is that inhibition of the
Na+/H+ exchanger will also affect cellular pH levels.
These agents have a plethora of other effects on cells
[117] suggesting they should be used with great cau-
tion if forming the sole criteria for macropinocytosis.
Studies proposing that uptake is via macropinocytosis
are also contradictory to others that demonstrate pep-
tide inhibition by agents that disrupt uptake by clathrin
coated vesicles [88].
Downstream of the plasma membrane, HIV-TAT
peptide and octaarginine co-localize with markers of
early endosomes [94, 108, 118] but there is some
controversy regarding the subsequent fate of the
peptides; and this aspect of their intracellular dynam-
ics is, as noted, is extremely important for drug deliv-
ery applications. Analysis using confocal microscopy
is often difficult to interpret as the possibility exists
that a proportion of the signal is emanating from par-
tially degraded peptide, and if the pH-sensitive fluo-
rophore fluorescein isothiocyanate is used as a label,
then its emission will be significantly diminished with-
in endosomes and especially lysosomes. Our studies
suggest that a major fraction of octaarginine and
HIV-TAT peptide in leukaemia and HeLa cells, is rap-
idly delivered to lysosomes [110], though other stud-
ies suggest that lysosomes are bypassed by a pene-
tratin peptide that was trafficked from endosomes to
the Golgi [119].
These endocytosis studies must also be reviewed
in parallel with those that clearly show energy inde-
pendent uptake of CPPs through the plasma mem-
brane [97, 98, 108, 110, 112]. Recent studies in
leukaemia cells suggest that R8 enters cells efficient-
ly at 4C but at temperatures ≥12C the same cell
may internalize the peptide by endocytosis and direct
plasma membrane translocation; the relative contri-
bution of each is dependent on temperature and the
peptide concentration [112]. This raises the possibili-
ty that entry into the cytosol from the extracellular
media or the endo-lysosome lumen occurs via a sim-
ilar concentration dependent mechanism (Fig. 3).
Model membrane systems have also been utilized to
investigate the binding and translocation capacities
of a number of CPPs and highlight the dependency
of peptide sequence and lipid composition of the
membranes. Proposed models include those sug-
gesting that CPPs are driven via a potential differ-
ence following membrane destabilization, that they
induce the formation of inverted micelles or that they
themselves mediate pore formation [84]. In view of
the significant differences in sequences and proper-
ties of peptides included in the CPP family, there are
Table 1 Sequences of the most studied CPPs with
respect to endocytic uptake
Peptide Sequence
HIV TAT peptide YGRKKRRQRRR
Octaarginine RRRRRRRR
SynB1 RGGRLSYSRRRFSTSTGR
Penetratin (Ant) RQIKIWFQNRRMKWKK
Transportan GWTLNSAGYLLGKINLKALAALAKKIL
HIV-gp41 fusion
peptide
GALFLGFLGAAGSTMGA
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likely to be more than one mechanism by which they
traverse lipid barriers.
Conclusions
Further studies of macropinocytosis in different cell
types will undoubtedly shed more light on this poorly
understood endocytic mechanism. The hunt will con-
tinue for unique markers or regulators of this process
and more specific inhibitory drugs, and these will
then allow for a better understanding of the factors
governing the formation and maturation of the nas-
cent macropinosome and its fate once released from
the plasma membrane.
The jury is clearly still out with regards to whether
the interaction of CPPs with cells induces a specific
form of macropinocytosis and enhances internaliza-
tion by one or more forms of endocytosis. At the rel-
atively high concentrations (number of peptide mole-
cules per cell) typically used to study these peptides
by fluorescent microscopy (typically 1–10 µM with 
1  105–5  105 cells) it is likely that the peptides
enter through multiple pathways in the fluid phase and
via non-specific adsorptive endocytosis. CPPs will
undoubtedly pose many more fascinating questions
as their intracellular dynamics is further stud-ied. A
more daunting challenge in drug delivery research is to
identify the route of translocation of the active moiety,
Fig. 3 Proposed model for the cellular entry of cationic cell penetrating peptides HIV-TAT and R8. Uptake of the 
peptides occurs by at least two temperature and concentration dependent mechanisms [112]. At 4C, entry can only
occur via plasma membrane translocation. At 37C and at high, threshold, extracellular concentration the peptide may
enter the cell via a number of endocytic pathways and via direct plasma membrane translocation. A number of endo-
cytic pathways including macropinocytosis caused by peptide induced plasma membrane ruffling is likely to be utilized.
Escape from undefined endosomal compartments (?) could conceivably be the result of the accumulation of the pep-
tide to a similar threshold concentration that promotes translocation across the plasma membrane.
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as opposed to what is seen through a microscope
lens, that then mediates a biological response.
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